Thioaptamers targeting dengue virus type-2 envelope protein domain III

Biochemical and Biophysical Research Communications

Volumn 453, Issue 3, 2014, Pages 309-315

  Gandham, Sai Hari A ^a   Volk, David E ^a,b   Lokesh, Ganesh L R ^a,b   Neerathilingam, Muniasamy ^a,c   Gorenstein, David G ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

Anti viral; Dengue virus; Diagnostic agent; Envelope protein; SELEX; Thioaptamer

Indexed keywords

ANTIVIRUS AGENT; APTAMER; DIAGNOSTIC AGENT; ENVELOPE PROTEIN; EPITOPE; NEUTRALIZING ANTIBODY; THIOAPTAMER; THIOAPTAMER TARGETING DENGUE VIRUS TYPE 2 ENVELOPE PROTEIN; UNCLASSIFIED DRUG; VACCINE; VIRUS PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DISSOCIATION CONSTANT; PROTEIN DOMAIN; CHEMISTRY; DENGUE VIRUS; DRUG EFFECTS; IMMUNOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE SEQUENCE;

DENGUE VIRUS; DENGUE VIRUS TYPE 2;

ANTIBODIES, NEUTRALIZING; ANTIVIRAL AGENTS; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; DENGUE VIRUS; MAGNETIC RESONANCE SPECTROSCOPY; VIRAL ENVELOPE PROTEINS;

EID: 84918572011     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.09.053     Document Type: Article

References (26)

1. M.G. Guzman, S.B. Halstead, H. Artsob, P. Buchy, J. Farrar, D.J. Gubler, et al., Dengue: a continuing global threat, Nat. Rev. Microbiol. 8 (2010) S7-S16.
2. Y. Zhang, W. Zhang, S. Ogata, D. Clements, J.H. Strauss, T.S. Baker, et al., Conformational changes of the flavivirus E glycoprotein, Structure 12 (2004) 1607-1618.
3. Y. Modis, S. Ogata, D. Clements, S.C. Harrison, Structure of the dengue virus envelope protein after membrane fusion, Nature 427 (2004) 313-319.
4. R.J. Kuhn, W. Zhang, M.G. Rossmann, S.V. Pletnev, J. Corver, E. Lenches, et al., Structure of dengue virus: implications for flavivirus organization, maturation, and fusion, Cell 108 (2002) 717-725.
5. S. Bhardwaj, M. Holbrook, R.E. Shope, A.D. Barrett, S.J. Watowich, Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein, J. Virol. 75 (2001) 4002-4007.
6. D.E. Volk, Y.C. Lee, X. Li, V. Thiviyanathan, G.D. Gromowski, L. Li, et al., Solution structure of the envelope protein domain III of dengue-4 virus, Virology 364 (2007) 147-154.
7. D.E. Volk, K.M. Anderson, S.H. Gandham, F.J. May, L. Li, D.W. Beasley, et al., NMR assignments of the sylvatic dengue 1 virus envelope protein domain III, Biomol. NMR Assign. 2 (2008) 155-157.
8. D.E. Volk, F.J. May, S.H. Gandham, A. Anderson, J.J. Von Lindern, D.W. Beasley, et al., Structure of yellow fever virus envelope protein domain III, Virology 394 (2009) 12-18.
9. D.E. Volk, S.H. Gandham, F.J. May, A. Anderson, A.D. Barrett, D.G. Gorenstein, NMR assignments of the yellow fever virus envelope protein domain III, Biomol. NMR Assign. 1 (2007) 49-50.
10. S.M. Lok, V. Kostyuchenko, G.E. Nybakken, H.A. Holdaway, A.J. Battisti, S. Sukupolvi-Petty, et al., Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins, Nat. Struct. Mol. Biol. 15 (2008) 312-317.
11. X. Yang, H. Wang, D.W. Beasley, D.E. Volk, X. Zhao, B.A. Luxon, et al., Selection of thioaptamers for diagnostics and therapeutics, Ann. N.Y. Acad. Sci. 1082 (2006) 116-119.
12. D.H. Bunka, O. Platonova, P.G. Stockley, Development of aptamer therapeutics, Curr. Opin. Pharm. 10 (2010) 557-562.
13. A. Somasunderam, V. Thiviyanathan, T. Tanaka, X. Li, M. Neerathilingam, G.L. Lokesh, et al., Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44, Biochemistry 49 (2010) 9106-9112.
14. D.J. King, D.A. Ventura, A.R. Brasier, D.G. Gorenstein, Novel combinatorial selection of phosphorothioate oligonucleotide aptamers, Biochemistry 37 (1998) 16489-16493.
15. J. Kang, M.S. Lee, J.A. Copland, B.A. Luxon, D.G. Gorenstein, Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein, Bioorg. Med. Chem. Lett. 18 (2008) 1835-1839.
16. D.G. Higgins, P.M. Sharp, CLUSTAL: a package for performing multiple sequence alignment on a microcomputer, Gene 73 (1988) 237-244.
17. M. Zuker, Mfold web server for nucleic acid folding and hybridization prediction, Nucleic Acids Res. 31 (2003) 3406-3415.
18. C.P. Woodbury Jr., P.H. von Hippel, On the determination of deoxyribonucleic acid-protein interaction parameters using the nitrocellulose filter-binding assay, Biochemistry 22 (1983) 4730-4737.
19. J. Kang, M.S. Lee, D.G. Gorenstein, Quantitative analysis of chemiluminescence signals using a cooled charge-coupled device camera, Anal. Biochem. 345 (2005) 66-71.
20. C.J. Wienken, P. Baaske, U. Rothbauer, D. Braun, S. Duhr, Protein-binding assays in biological liquids using microscale thermophoresis, Nat. Comm. 1 (2010) 100.
21. D. Irvine, C. Tuerk, L. Gold Selexion, Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis, J. Mol. Biol. 222 (3) (1991) 739-761.
22. X. Lou, J. Qian, Y. Xiao, L. Viel, A.E. Gerdon, E.T. Lagally, et al., Micromagnetic selection of aptamers in microfluidic channels, PNAS 106 (2009) 2989-2994.
23. C. Tuerk, L. Gold, Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase, Science 249 (1990) 505-510.
24. S.C. Gopinath, Methods developed for SELEX, Anal. Bioanal. Chem. 387 (2007) 171-182.
25. C. Hamula, J. Guthrie, H. Zhang, X.-F. Li, X.C. Le, Selection and analytical applications of aptamers, Trends Anal. Chem. 25 (7) (2006) 681-691.
26. K.C. Huang et al., Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein, Proteins 70 (3) (2008) 1116-1119.